Soc. Generale Call 110 MS 21.06.2.../ DE000SQ4FQ20 /
13/06/2024 8:55:01 | Diferencia- | Bid11:05:09 | Ask11:05:09 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.001EUR | - | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
Morgan Stanley | 110.00 USD | 21/06/2024 | Call |
GlobeNewswire
13:30
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
13:30
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
GlobeNewswire
13:30
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective an...
GlobeNewswire
13:30
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
13:30
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...
GlobeNewswire
13:14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
13:01
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 V...
GlobeNewswire
13:00
Correction: 仙境传说:破晓 (Ragnarok: Dawn, Tentative English Title) Received an ISBN from the Chinese Gove...
GlobeNewswire
13:00
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
13:00
Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by t...
GlobeNewswire
13:00
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter ...
GlobeNewswire
13:00
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página